EpiVax Therapeutics

Haptena Therapeutics

This biotechnology company develops immunotherapies for patients with oncogene-driven cancers by integrating precision oncology with immune engineering.

Hubro Therapeutics

This company develops neoantigen-targeted cancer vaccines for patients with gastrointestinal cancers to activate anti-cancer specific T-cell immune responses.

Infinitopes

This biotechnology company develops precision therapeutic cancer vaccines and antigen discovery platforms for healthcare providers and patients with solid tumours.

myNEO Therapeutics

This company develops AI-driven cancer vaccines and immunotherapy targets from the dark genome for biopharmaceutical partners and clinical applications.

Cartography

This precision immunotherapy company develops targeted cancer therapies and an antigen atlas for medical researchers to identify cell-specific treatment targets.

Revealis Biotherapeutics

This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.

ImmuneSpec

This company provides immunopeptidomics analysis services to biotechnology and pharmaceutical firms to support vaccine development, immunotherapy research and biotherapeutic immunogenicity risk assessment.

Vectiopep

This company develops peptide-based nucleic acid delivery technology for biotechnology firms and researchers to create targeted messenger RNA cancer immunotherapies.